» Authors » Jimmy Mullaert

Jimmy Mullaert

Explore the profile of Jimmy Mullaert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 286
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Avramenko A, Etienne H, Weisenburger G, Mullaert J, Cerceau P, Pellenc Q, et al.
Respir Med Res . 2024 Sep; 86:101139. PMID: 39299136
Introduction: With increasing experience in high-volume centers, age alone should not be an absolute contra-indication to lung transplantation (LT) but be considered as part of the patient's initial characteristics. The...
2.
Kadouch D, Picon E, Mullaert J, Delestre F, Vitiello D, Roussel R, et al.
Clin Nutr ESPEN . 2024 Jul; 63:972-978. PMID: 38991939
Aim: To describe lipid oxidation during physical activity (PA) in overweight and obese patients using a real-time capillary glycerol sensor and to propose a personalized strategy to optimize lipolysis. Methods:...
3.
Milenkov M, Proux C, Rasolofoarison T, Rakotomalala F, Rasoanandrasana S, Rahajamanana V, et al.
Lancet Microbe . 2024 Jun; 5(8):100850. PMID: 38908389
Background: Antimicrobial resistance (AMR) is a major public health threat, affecting not only people but also animals and the environment. The One Health dimension of AMR is well known; however,...
4.
Kim H, Mullaert J, Tondreau A, Park B, Rouzier R
Sci Rep . 2024 Jun; 14(1):13845. PMID: 38879675
Knowing the mean age at diagnosis of breast cancer (BC) in a country is important for setting up an efficient BC screening program. The aim of this study was to...
5.
Frija J, Mullaert J, Abensur Vuillaume L, Grajoszex M, Wanono R, Benzaquen H, et al.
J Sleep Res . 2024 Jun; :e14235. PMID: 38873908
Sleep trackers are used widely by patients with sleep complaints, however their metrological validation is often poor and relies on healthy subjects. We assessed the metrological validity of two commercially...
6.
Tebeka S, Gloaguen E, Mullaert J, He Q, Boland A, Deleuze J, et al.
Eur Psychiatry . 2024 Mar; :1-36. PMID: 38555957
No abstract available.
7.
dHumieres C, Delavy M, Alla L, Ichou F, Gauliard E, Ghozlane A, et al.
Microbiome . 2024 Mar; 12(1):50. PMID: 38468305
Background: Antibiotics notoriously perturb the gut microbiota. We treated healthy volunteers either with cefotaxime or ceftriaxone for 3 days, and collected in each subject 12 faecal samples up to day...
8.
Lavalley-Morelle A, Mentre F, Comets E, Mullaert J
Comput Methods Programs Biomed . 2024 Feb; 247:108095. PMID: 38422892
Background And Objective: Joint modeling of longitudinal and time-to-event data has gained attention over recent years with extensive developments including nonlinear models for longitudinal outcomes and flexible time-to-event models for...
9.
Catozzi S, Assaad S, Delrieu L, Favier B, Dumas E, Hamy A, et al.
Eur J Cancer . 2024 Feb; 199:113571. PMID: 38301362
Introduction: Recent retrospective studies suggest potential large patient's benefit through proper timing of immune checkpoint blockers (ICB). The association between ICB treatment timing and patient survival, neoplastic response and toxicities...
10.
Lavalley-Morelle A, Peiffer-Smadja N, Gressens S, Souhail B, Lahens A, Bounhiol A, et al.
Biom J . 2023 Nov; 66(1):e2300049. PMID: 37915123
During the coronavirus disease 2019 (COVID-19) pandemic, several clinical prognostic scores have been proposed and evaluated in hospitalized patients, relying on variables available at admission. However, capturing data collected from...